A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Clinical trial NCT06568692 · RECRUITING

Trial details

NCT number: NCT06568692
Sponsor: Processa Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer TNBC - Triple-Negative Breast Cancer HER2-negative Breast Cancer

Start date: 2024-10-02
Primary completion: 2026-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.